QGRW
U.S. Quality Growth Fund

Published February 18, 2025
Director, Quantitative Research
Director, Research
For years, the NASDAQ 100 has been the dominant benchmark for growth investors in the U.S. markets, known for its heavy exposure to technology and innovation-driven companies. The methodology is straightforward—the 100 largest non-financial companies by market capitalization listed on the NASDAQ exchange are selected for inclusion, with constituents weighted by modified market capitalization.
However, this simplicity can come with trade-offs. Since the NASDAQ 100 does not apply fundamental selection criteria, mature, slow-growth companies can enter the index purely due to their size, potentially diluting the growth exposure that investors seek.
In contrast, the WisdomTree U.S. Quality Growth Index deploys a fundamentals-based selection process, identifying high-growth companies with strong profitability metrics across all major U.S. exchanges. This broader and more refined methodology has led to outperformance of more than 15% over the NASDAQ 100 since its launch in November 2022, a period when the NASDAQ 100 itself posted strong gains.


Sources: WisdomTree, NASDAQ, as of 12/31/24. You cannot invest directly in an index.
While there is significant overlap in holdings, WisdomTree's selection methodology results in a differentiated portfolio, emphasizing earnings and sales growth as key factors.
To highlight the contrast in methodology, below are the five largest unique holdings in each index:
Top Unique Stocks in WisdomTree U.S. Quality Growth:
Top Unique Stocks in NASDAQ 100 (excluded from WisdomTree due to profitability and growth screens):

Sources: WisdomTree, FactSet, Bloomberg, as of 12/31/24. You cannot invest directly in an index.
A few observations from above:

Sources: WisdomTree, FactSet, Bloomberg. Returns from 12/15/22 to 12/31/24 (earliest common history) are derived from the total return series. Historical performance is not an indication of future performance, and any investment may go down in value.
Looking at the performance attribution numbers of the WisdomTree U.S. Quality Growth Fund (QGRW), which tracks the WTQGRW Index, relative to the Invesco QQQ Trust (QQQ), which tracks the Nasdaq 100 Index, we can see the breakdown of the outperformance since December 2022. In this two-year period, QGRW has outperformed QQQ by 5.6% on an annualized basis. The outperformance can be partly attributed to the over-weight allocation to Financials, including companies like Visa, Mastercard and Blackstone; and the under-weight allocation to Consumer Staples, avoiding names like PepsiCo and Costco. The other driver of outperformance is stock selection within the Information Technology sector, which is seen with the addition of AppLovin Corp during the December 2023 rebalance, the avoidance of laggards like Intel and the weighting of certain Magnificent Seven names.
By applying a fundamentals-based selection process across all U.S. exchanges, the WisdomTree U.S. Quality Growth Fund seeks to provide a better proxy for growth investing than traditional market cap weighted indexes like the NASDAQ 100.
QGRW seeks to:
As investors continue to seek high-quality growth opportunities, a fundamentals-driven approach like WisdomTree's may offer a superior way to access long-term, sustainable growth.
For current Fund holdings, click here. Holdings are subject to risk and change.
There are risks associated with investing, including the possible loss of principal. Please read the Fund’s prospectus for specific details regarding the Fund’s risk profile. Growth stocks, as a group, may be out of favor with the market and underperform value stocks or the overall equity market. Growth stocks are generally more sensitive to market movements than other types of stocks. The Fund is non-diversified and, as a result, changes in the market value of a single security could cause greater fluctuations in the value of Fund shares than would occur in a diversified fund. The Fund invests in the securities included in, or representative of, its Index regardless of their investment merit. The Fund does not attempt to outperform its Index or take defensive positions in declining markets and the Index may not perform as intended.
U.S. Quality Growth Fund

Director, Quantitative Research
Ayush Babel is the Director of Quantitative Research in WisdomTree's multi-asset quantitative research and index teams. In this role, he focuses on developing innovative quantitative strategies across various asset classes while supporting WisdomTree's diverse range of products. His expertise spans factor exploration, portfolio construction and optimization, quantitative investment research, and product development.
With over a decade of experience in the financial services industry, Ayush has held investment research roles at J.P. Morgan and Franklin Templeton. At these institutions, he was responsible for developing and managing equity and fixed income smart beta products, as well as cross-asset risk premia solutions for global institutional and retail clients. His experience covers a broad spectrum of asset classes and investment styles.
Ayush holds a bachelor's in Engineering Physics and a master’s degree in Nanoscience from the Indian Institute of Technology, Bombay.

Director, Research
Matt Wagner joined WisdomTree in May 2017 as an Analyst on the Research team. He currently serves as a Director, where he supports the creation, maintenance, and reconstitution of WisdomTree’s indexes and actively managed ETFs. Matt began his career at Morgan Stanley, working as an analyst in Treasury Capital Markets from 2015 to 2017, focusing on unsecured funding planning, execution, and risk management. He graduated magna cum laude from Boston College in 2015 with a B.A. in International Studies, concentrating in Economics. In 2020, he earned a Certificate in Advanced Valuation from NYU Stern. He is also a Chartered Financial Analyst (CFA) charterholder.